Modeling the Potential Impacts of Outpatient Antiviral Treatment in Reducing Influenza-Associated Hospitalizations in the United States

Sinead E Morris, Sarabeth M Mathis, Emily Reeves, Jessie R Chung, Rebecca K Borchering, Nathaniel M Lewis, Svetlana Masalovich, Shikha Garg, Timothy M Uyeki, A Danielle Iuliano, Mark W Tenforde, Carrie Reed, Matthew Biggerstaff
{"title":"Modeling the Potential Impacts of Outpatient Antiviral Treatment in Reducing Influenza-Associated Hospitalizations in the United States","authors":"Sinead E Morris, Sarabeth M Mathis, Emily Reeves, Jessie R Chung, Rebecca K Borchering, Nathaniel M Lewis, Svetlana Masalovich, Shikha Garg, Timothy M Uyeki, A Danielle Iuliano, Mark W Tenforde, Carrie Reed, Matthew Biggerstaff","doi":"10.1093/infdis/jiaf061","DOIUrl":null,"url":null,"abstract":"Background Seasonal influenza causes an estimated 120 000 to 710 000 hospitalizations annually in the United States. Treatment with antiviral medications, such as oseltamivir, can reduce risks of hospitalization among people with influenza-associated illness. The US Centers for Disease Control and Prevention recommends initiating antiviral treatment as soon as possible for outpatients with suspected or confirmed influenza who have severe or progressive illness or are at higher risk of influenza complications. Methods We developed a probabilistic model to estimate the impact of antiviral treatment in reducing hospitalizations among US outpatients with influenza. Parameters were informed by seasonal influenza surveillance platforms and stratified by age group and whether individuals had a condition associated with higher risk of influenza complications. We modeled different scenarios for influenza antiviral effectiveness and outpatient testing and prescribing practices, then compared our results with a baseline scenario in which antivirals were not used. Results Across the modeled scenarios, antiviral treatment resulted in 1215 to 14 184 fewer influenza-associated hospitalizations on average when compared with the baseline scenario (0.2%–2.7% reduction). The greatest effects occurred among adults aged ≥65 years and individuals with conditions associated with higher risk of influenza complications. Modeling 50% improvements in access to care, testing, prescribing, and treatment resulted in greater potential impacts, with over 71 000 (13.3%) influenza-associated hospitalizations averted on average compared to baseline. Conclusions Our results support recommendations to prioritize outpatient antiviral treatment among older adults and others at higher risk of influenza complications. Improving access to prompt testing and treatment among outpatients with suspected influenza could reduce hospitalizations substantially.","PeriodicalId":501010,"journal":{"name":"The Journal of Infectious Diseases","volume":"27 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/infdis/jiaf061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background Seasonal influenza causes an estimated 120 000 to 710 000 hospitalizations annually in the United States. Treatment with antiviral medications, such as oseltamivir, can reduce risks of hospitalization among people with influenza-associated illness. The US Centers for Disease Control and Prevention recommends initiating antiviral treatment as soon as possible for outpatients with suspected or confirmed influenza who have severe or progressive illness or are at higher risk of influenza complications. Methods We developed a probabilistic model to estimate the impact of antiviral treatment in reducing hospitalizations among US outpatients with influenza. Parameters were informed by seasonal influenza surveillance platforms and stratified by age group and whether individuals had a condition associated with higher risk of influenza complications. We modeled different scenarios for influenza antiviral effectiveness and outpatient testing and prescribing practices, then compared our results with a baseline scenario in which antivirals were not used. Results Across the modeled scenarios, antiviral treatment resulted in 1215 to 14 184 fewer influenza-associated hospitalizations on average when compared with the baseline scenario (0.2%–2.7% reduction). The greatest effects occurred among adults aged ≥65 years and individuals with conditions associated with higher risk of influenza complications. Modeling 50% improvements in access to care, testing, prescribing, and treatment resulted in greater potential impacts, with over 71 000 (13.3%) influenza-associated hospitalizations averted on average compared to baseline. Conclusions Our results support recommendations to prioritize outpatient antiviral treatment among older adults and others at higher risk of influenza complications. Improving access to prompt testing and treatment among outpatients with suspected influenza could reduce hospitalizations substantially.
模拟门诊抗病毒治疗对减少美国流感相关住院的潜在影响
背景:在美国,季节性流感每年导致约12万至71万人住院。用奥司他韦等抗病毒药物治疗可降低流感相关疾病患者住院的风险。美国疾病控制和预防中心建议,对于患有严重或进展性流感或流感并发症风险较高的疑似或确诊流感门诊患者,应尽快开始抗病毒治疗。方法:我们建立了一个概率模型来估计抗病毒治疗对减少美国流感门诊患者住院率的影响。参数由季节性流感监测平台提供,并根据年龄组和个人是否患有与流感并发症高风险相关的疾病进行分层。我们模拟了流感抗病毒药物有效性、门诊测试和处方实践的不同情景,然后将我们的结果与未使用抗病毒药物的基线情景进行了比较。结果在所有模拟情景中,与基线情景相比,抗病毒治疗导致流感相关住院平均减少1215至14184例(减少0.2%-2.7%)。最大的影响发生在年龄≥65岁的成年人和流感并发症风险较高的个体中。在获得护理、检测、处方和治疗方面,50%的改善带来了更大的潜在影响,与基线相比,平均避免了超过71000例(13.3%)流感相关住院。结论:我们的研究结果支持在老年人和其他流感并发症高风险人群中优先进行门诊抗病毒治疗的建议。改善门诊疑似流感患者获得及时检测和治疗的机会,可大大减少住院人数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信